###begin article-title 0
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
A novel WFS1 mutation in a family with dominant low frequency sensorineural hearing loss with normal VEMP and EcochG findings
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 134 147 134 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIAPH1, MYO7A</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1</italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
Low frequency sensorineural hearing loss (LFSNHL) is an uncommon clinical finding. Mutations within three different identified genes (DIAPH1, MYO7A, and WFS1) are known to cause LFSNHL. The majority of hereditary LFSNHL is associated with heterozygous mutations in the WFS1 gene (wolframin protein). The goal of this study was to use genetic analysis to determine if a small American family's hereditary LFSNHL is linked to a mutation in the WFS1 gene and to use VEMP and EcochG testing to further characterize the family's audiovestibular phenotype.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
The clinical phenotype of the American family was characterized by audiologic testing, vestibular evoked myogenic potentials (VEMP), and electrocochleography (EcochG) evaluation. Genetic characterization was performed by microsatellite analysis and direct sequencing of WFS1 for mutation detection.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
Sequence analysis of the WFS1 gene revealed a novel heterozygous mutation at c.2054G>C predicting a p.R685P amino acid substitution in wolframin. The c.2054G>C mutation segregates faithfully with hearing loss in the family and is absent in 230 control chromosomes. The p.R685 residue is located within the hydrophilic C-terminus of wolframin and is conserved across species. The VEMP and EcochG findings were normal in individuals segregating the WFS1 c.2054G>C mutation.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
We discovered a novel heterozygous missense mutation in exon 8 of WFS1 predicting a p.R685P amino acid substitution that is likely to underlie the LFSNHL phenotype in the American family. For the first time, we describe VEMP and EcochG findings for individuals segregating a heterozygous WFS1 mutation.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
Hearing loss is a common disorder affecting the communication abilities of more than 28 million Americans. A variety of etiologies for hearing loss have been identified including aging, noise exposure, ototoxic medications, and genetics. Over 90 different genetic loci have been linked to hereditary auditory impairment [1]. The majority of these loci are associated with high frequency hearing loss or a deficit affecting all frequencies, with only four loci linked to low frequency hearing loss. It is not well understood why autosomal dominant mutations at these four loci cause low frequency hearing loss as opposed to reduced sensitivity in the higher frequencies.
###end p 11
###begin p 12
###xml 106 127 106 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA1, DFNA11, DFNA54</italic>
###xml 133 145 133 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA6/14/38 </italic>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFN</italic>
###xml 217 218 217 218 <underline xmlns:xlink="http://www.w3.org/1999/xlink">d</underline>
###xml 220 222 220 222 <underline xmlns:xlink="http://www.w3.org/1999/xlink">fn</underline>
###xml 242 244 242 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A </italic>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA1</italic>
###xml 458 465 458 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIAPH1 </italic>
###xml 484 505 484 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila diaphanous</italic>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 558 565 558 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA11 </italic>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYO7A</italic>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 717 724 717 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA54 </italic>
###xml 802 803 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 853 864 853 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA6/14/38</italic>
###xml 945 949 945 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1</italic>
###xml 952 953 952 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 954 955 954 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 484 494 <span type="species:ncbi:7227">Drosophila</span>
Non-syndromic autosomal dominant low frequency sensorineural hearing loss (LFSNHL) has been mapped to the DFNA1, DFNA11, DFNA54, and DFNA6/14/38 loci. These four loci are described by the letters DFN, which stand for deafness, and the letter A to indicate autosomal dominant inheritance. The loci are labeled with a number indicating the order in which they were discovered. DFNA1, the first identified locus for LFSNHL, is associated with a mutation in the DIAPH1 gene (homologue of Drosophila diaphanous) and has been reported in only a single family [2]. DFNA11 represents a second LFSNHL locus, where a heterozygous mutation in myosin VIIA (MYO7A) found in only a single family leads to non-syndromic LFSNHL [3]. DFNA54 was mapped to LFSNHL in one family, but the gene has not yet been identified [4]. The fourth and most common locus for LFSNHL is DFNA6/14/38, which results from heterozygous mutations in the Wolfram syndrome type 1 gene (WFS1) [5-7].
###end p 12
###begin p 13
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 279 287 <span type="species:ncbi:9606">children</span>
The hearing loss associated with autosomal dominant mutations in WFS1 is primarily bilateral and symmetric. The age of onset of hearing loss appears to occur before age 10 and initially affects 250, 500 and 1000 Hz [8]. The mild hearing loss in the low frequencies seen in young children generally progresses to a moderate hearing loss in the low and mid frequencies by the second decade of life and then to a moderate to severe loss across the frequency range after age 40 [7]. Homozygous mutations in WFS1 have been linked to the recessively inherited Wolfram syndrome, a syndrome whose features include diabetes insipidus, diabetes mellitus, optic atrophy and sensorineural hearing loss in the high frequencies [9].
###end p 13
###begin p 14
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 275 280 <span type="species:ncbi:10090">mouse</span>
WFS1 encodes for wolframin, an 890 amino acid protein of unknown function, which has been localized to the endoplasmic reticulum [10]. Wolframin is predicted to have nine transmembrane spanning domains with a hydrophilic N- and C-terminus [11]. Wolframin is expressed in the mouse inner ear throughout postnatal development (P1, 7, 14, 35) in a variety of cell types including outer and inner hair cells, support cells, spiral ganglion neurons and vestibular hair cells [12]. No wolframin expression gradient is observed between the apical and basal ends of the cochlea.
###end p 14
###begin p 15
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 824 829 824 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
Despite high levels of wolframin expression in the vestibular hair cells [12], individuals with heterozygous WFS1 mutations and LFSNHL generally do not complain of vestibular difficulty [7,8,13-17]. Ocular motor, caloric and vestibular ocular reflex testing have not revealed any consistent vestibular dysfunction in patients with Wolfram's syndrome or individuals with heterozygous WFS1 mutations and LFSNHL [15,17-21]. Previous vestibular testing for individuals with heterozygous and homozygous WFS1 mutations has targeted the semicircular canals. To our knowledge, no clinical testing of otolith function such as the vestibular evoked myogenic potential (VEMP) has been completed in individuals with WFS1 mutations. In addition, the literature does not report electrocochleography (EcochG) findings for individuals with WFS1 mutations even though LFSNHL has also been associated with endolymphatic hydrops [22].
###end p 15
###begin p 16
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
The goal of this study was to use genetic analysis to determine if a small American family's hereditary LFSNHL is linked to a mutation in the WFS1 gene and to use VEMP and EcochG testing to further characterize the family's audiovestibular phenotype.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Research subjects and controls
###end title 18
###begin p 19
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
To facilitate microsatellite and sequence analysis, blood samples were collected by venipuncture from four unaffected and three affected family members and 115 predominantly Caucasian control subjects for high molecular weight DNA isolation using standard techniques. Control subjects were screened to ensure that they had normal hearing for their age as previously described [3]. Individuals gave written informed consent according to a protocol approved by the Institutional Review Board (IRB) of the University of Washington.
###end p 19
###begin title 20
Auditory assessment
###end title 20
###begin p 21
###xml 427 438 <span type="species:ncbi:9606">participant</span>
Audiologic evaluations were either conducted as part of this study or obtained from previous test results that were released to the study. Audiograms were obtained by a certified audiologist for seven affected members of the family in either a sound treated booth or a quiet room during a family reunion. Immittance testing was used to evaluate middle-ear pressure, ear canal volume, and tympanic membrane mobility. Each study participant completed a hearing and balance questionnaire to assess his or her medical and noise-exposure history.
###end p 21
###begin title 22
VEMP and EcochG assessment
###end title 22
###begin p 23
###xml 130 166 130 166 <underline xmlns:xlink="http://www.w3.org/1999/xlink">Vestibular Evoked Myogenic Potential</underline>
###xml 553 573 553 573 <underline xmlns:xlink="http://www.w3.org/1999/xlink">Electrocochleography</underline>
###xml 361 367 <span type="species:ncbi:9606">Person</span>
###xml 907 914 <span type="species:ncbi:9606">Persons</span>
The VEMP and EcochG evaluations were conducted in the Otolaryngology - HNS Clinic testing suites at the University of Washington. Vestibular Evoked Myogenic Potential (VEMP) uses a high intensity auditory stimulus to elicit a neck muscle response for assessment of saccular function. Abnormal saccular function is indicated by the absence of the VEMP response. Person 20 was presented monaurally with 250 clicks at 5 Hz and 100 dB nHL. Potentials across the ventral neck muscles were recorded bilaterally using electromyography with surface electrodes. Electrocochleography (EcochG) measures an auditory evoked response generated by the cochlea and auditory nerve. The EcochG response consists of the cochlear microphonic, the summating potential (SP), and the action potential (AP). An increased SP/AP amplitude ratio is often used as a diagnostic indicator of endolymphatic hydrops and Meniere's disease. Persons 20 and 26 were tested using the Nicolet Spirit evoked potential system. Electrodes were placed on the forehead and tiptrodes inserted into the ear canals. Click stimuli were presented at a rate of 11.4 per second. Response waveforms were obtained for an alternating polarity stimulus over a 10 ms time window and for condensation and rarefaction stimuli over 5 ms. Responses were recorded with filter settings of 20-3000 Hz and averaged over 800-1000 sweeps.
###end p 23
###begin title 24
Microsatellite marker, DNA sequence, and protein bioinformatics analysis
###end title 24
###begin p 25
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA1</italic>
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA11</italic>
###xml 47 59 47 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA4/16/38 </italic>
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA54 </italic>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
Microsatellite markers near the DFNA1, DFNA11, DFNA4/16/38 and DFNA54 loci were analyzed in seven family members. PCR products were multiplexed and separated by capillary electrophoresis on an ABI PRISM 310 Genetic Analyzer (PE Biosystems, Foster City, CA). Amplification products were sized according to CEPH (Centre d'Etude du Polymorphisme Humain) control DNA (1347-02) and assigned allele numbers consistent with the CEPH designations [23]. The inheritance pattern of the hearing loss was assumed to be autosomal dominant and fully penetrant.
###end p 25
###begin p 26
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
PCR primers for exons 1-8 and the immediate intron flanking regions were designed with the Primer 3 web-based program [24] and used to analyze the WFS1 gene in one unaffected and two affected family members (primer sequences available upon request). PCR incubation mixture, thermocycling conditions, and purification procedures for genomic amplification and sequencing were performed as described previously [25,26]. Electropherograms were analyzed using the CodonCode Aligner software package (CodonCode Corporation, Dedham, MA).
###end p 26
###begin p 27
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
The C-terminus region of wolframin (amino acids 657-890) was analyzed using The PSIPRED Structure Prediction Server [27-32] and FoldIndex [33].
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Low-frequency hearing loss
###end title 29
###begin p 30
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 268 273 <span type="species:ncbi:9606">child</span>
Affected family members demonstrated bilateral symmetric moderate or moderately-severe sensorineural hearing loss in the low frequencies, rising to normal or borderline normal at 4000 Hz and above (Fig. 1A). A moderate low frequency hearing loss found in a 4-year-old child suggests childhood onset of hearing loss (Fig. 1A). Longitudinal audiometric time points were available for females 20, 26, and 27 suggesting a slow rate of hearing loss progression in these three individuals (Fig. 1A). Speech audiometry results for two family members indicated speech discrimination ability within normal limits.
###end p 30
###begin p 31
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Audiologic and genetic characterization of the low frequency hearing loss pedigree.</bold>
###xml 83 88 83 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink"> (A) </bold>
###xml 938 942 938 942 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 1158 1162 1158 1162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 220 226 <span type="species:ncbi:9606">person</span>
###xml 358 365 <span type="species:ncbi:9606">persons</span>
###xml 869 875 <span type="species:ncbi:9606">person</span>
Audiologic and genetic characterization of the low frequency hearing loss pedigree. (A) Each individual in the pedigree is assigned a number. Underlined numbers indicate that auditory evaluations were performed for that person. Affected individuals are denoted by blackened symbols, males are denoted by squares, females are denoted by circles, and deceased persons are indicated by a diagonal line through the symbol. Blood drop symbols indicate individuals who donated a blood sample to the study. Symmetrical hearing loss was detected in all affected family members; therefore, only the right ear pure-tone air conduction thresholds are plotted on the audiograms. Frequency in hertz (Hz) is plotted on the x-axis and the hearing level in decibels (dB HL) on the y-axis. Plotted on each audiogram (gray line) are the average pure-tone air conduction thresholds for a person with normal hearing matched in age [39] to the family member. (B) Electropherograms showing a heterozygous c.2054G>C mutated genomic nucleotide sequence from an affected individual compared to a homozygous c.2054G unaffected family member. Nucleotide numbering starts with the ORF. (C) Protein alignment shows conservation of the p.R685 residue during evolution. The p.685P substitution in the pedigree is shown in red.
###end p 31
###begin title 32
Genetic analysis supports novel mutation in WFS1 exon 8
###end title 32
###begin p 33
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA1</italic>
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA11</italic>
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA54 </italic>
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4S432 </italic>
###xml 189 201 189 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA4/16/38 </italic>
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 800 805 <span type="species:ncbi:9606">human</span>
###xml 807 820 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 822 825 <span type="species:ncbi:9615">dog</span>
###xml 827 830 <span type="species:ncbi:9913">cow</span>
###xml 832 837 <span type="species:ncbi:10090">mouse</span>
###xml 839 842 <span type="species:ncbi:10116">rat</span>
###xml 853 860 <span type="species:ncbi:9031">chicken</span>
Microsatellite markers near the DFNA1, DFNA11, and DFNA54 loci did not cosegregate with hearing loss in the American pedigree. However, allele 6 (234 bp product) for marker D4S432 near the DFNA4/16/38 locus did cosegregate with hearing loss in the family, leading us to consider further the candidacy of the WFS1 gene by direct sequence analysis. Sequencing of WFS1 exon 8 revealed a c.2054G>C transversion (Fig. 1B) predicting a p.R685P amino acid substitution (Fig. 1C). Sequence analysis indicated the absence of this transversion in 230 control chromosomes. This heterozygous c.2054G>C change is consistent with the autosomal dominant inheritance observed for hearing loss in the family (Fig. 1A). The p.R685 residue is located within the hydrophilic C-terminus of wolframin and conserved across human, rhesus monkey, dog, cow, mouse, rat, opossum, chicken and frog (Fig. 1C).
###end p 33
###begin title 34
Protein bioinformatics predicts a folded Wolframin C-terminus
###end title 34
###begin p 35
Conserved structural protein motifs have not been identified in the C-terminus region of wolframin nor has a solved protein structure for this region been published. In this report, the C-terminus region of wolframin was analyzed using The PSIPRED Structure Prediction Server and FoldIndex. These protein bioinformatics programs suggest that the C-terminal region of wolframin adopts a folded confirmation. It is likely that the p.R685 residue is exposed on the surface of this folded domain where it could facilitate protein-to-protein interactions.
###end p 35
###begin title 36
Normal VEMP, and EcochG findings
###end title 36
###begin p 37
###xml 126 132 <span type="species:ncbi:9606">person</span>
###xml 211 218 <span type="species:ncbi:9606">persons</span>
No balance problems were self-reported by the family members on the intake questionnaire. The VEMP was present bilaterally in person 20. The EcochG test generated an SP/AP ratio within the normal range for both persons 20 and 26.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 1128 1133 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 1159 1160 1159 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1162 1164 1162 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1186 1188 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 572 578 <span type="species:ncbi:9606">humans</span>
###xml 596 609 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 611 616 <span type="species:ncbi:10090">mouse</span>
###xml 618 621 <span type="species:ncbi:10116">rat</span>
###xml 623 626 <span type="species:ncbi:9615">dog</span>
###xml 628 631 <span type="species:ncbi:9913">cow</span>
###xml 642 649 <span type="species:ncbi:9031">chicken</span>
###xml 1001 1006 <span type="species:ncbi:4932">yeast</span>
###xml 1032 1037 <span type="species:ncbi:9606">human</span>
###xml 1122 1127 <span type="species:ncbi:9606">human</span>
We identified a small Caucasian American family with hereditary autosomal dominant LFSNHL likely caused by a novel heterozygous c.2054G>C WFS1 mutation. The absence of this heterozygous c.2054G>C DNA alteration in 230 control chromosomes supports the hypothesis that it represents a causative mutation, not a rare polymorphism. The c.2054G>C DNA alteration cosegregates faithfully with hearing loss in the family and predicts a non-conservative p.R685P amino acid substitution in the wolframin protein. The arginine amino acid residue at position 685 is found not only in humans, but also in the rhesus monkey, mouse, rat, dog, cow, opossum, chicken and frog. Conservation of p.R685 over evolutionary time suggests that altering this residue could have deleterious consequences for the wolframin protein. The p.R685P amino acid substitution may alter the ability of the C-terminus domain to adopt a folded conformation or may impede interaction with a protein binding partner. A recent report using a yeast two-hybrid system with a human brain cDNA library suggests that the C-terminal domain (amino acids 652-890) of the human WFS1 gene interacts with the Na+/K+ ATPase beta1 subunit [34]. If a similar association exists within the inner ear, perhaps the p.R685P substitution alters this protein-to-protein interaction.
###end p 39
###begin p 40
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
Twenty-six other heterozygous WFS1 mutations linked to dominant low frequency sensorineural hearing loss have been described previously [35]. These known mutations include 25 point mutations and one small deletion, all found in the large exon 8 with the exception of two point mutations in exon 5. This wealth of mutational genetic heterogeneity within WFS1 will contribute useful information for uncovering the structure/function relationship of the wolframin protein in the auditory and vestibular system.
###end p 40
###begin p 41
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 772 777 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
###xml 736 742 <span type="species:ncbi:9606">person</span>
Previous vestibular testing focusing on semicircular canal function in individuals with WFS1 mutations yielded normal findings [15,17-21]. However, saccular dysfunction as assessed by the VEMP test has been shown to co-exist with normal semicircular canal responses in patients with connexin-26 mutations who do not complain of dizziness or unsteadiness [36] and in some patients with Meniere's disease who have normal caloric responses [37,38]. Given that normal semicircular canal function as assessed by clinical vestibular testing can not predict saccular function, the VEMP evaluation was extended to individuals with heterozygous WFS1 mutations and LFSNHL in this study for the first time. No saccular dysfunction was detected in person 26 segregating the c.2054G>C WFS1 mutation as this individual generated a normal VEMP response in both ears. This finding is interesting given that wolframin is expressed in vestibular hair cells [12] of the saccule (Guy van Camp, personal communication, 2007).
###end p 41
###begin p 42
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIAPH1 </italic>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 613 620 613 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIAPH1 </italic>
###xml 756 763 756 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIAPH1 </italic>
###xml 74 77 <span type="species:ncbi:9606">boy</span>
###xml 444 451 <span type="species:ncbi:9606">persons</span>
###xml 593 596 <span type="species:ncbi:9606">man</span>
LFSNHL has also been associated with endolymphatic hydrops. An 8-year-old boy with LFSNHL and a DIAPH1 mutation was evaluated with EcochG and found to have an elevated SP/AP ratio, suggestive of endolymphatic hydrops [22]. To determine if abnormal EcochG findings were a trait of other dominant LFSNHL mutations, we provided two individuals segregating the c.2054G>C WFS1 mutation with an EcochG evaluation. The SP/AP ratio was normal for both persons 20 and 26, which suggests the absence of endolymphatic hydrops in these two individuals. It would be interesting to follow-up with the young man segregating the DIAPH1 mutation and other individuals in his family affected by LFSNHL to determine if an elevated EcochG SP/AP ratio is characteristic of the DIAPH1 mutation.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1 </italic>
We identified a small Caucasian American family presenting with hereditary autosomal dominant LFSNHL. Genetic analysis of the family revealed a heterozygous c.2054G>C WFS1 mutation that cosegregates with the hearing loss found in the family. This mutation, absent in 230 control chromosomes, predicts a non-conservative p.R685P substitution. For the first time, we describe VEMP and EcochG findings for individuals segregating a heterozygous WFS1 mutation, with both diagnostic tests yielding normal findings in this family.
###end p 44
###begin title 45
Abbreviations
###end title 45
###begin p 46
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WFS1</italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DFNA</italic>
###xml 201 207 201 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIAPH1</italic>
###xml 209 219 209 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">diaphanous</italic>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYO7A</italic>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYO7A</italic>
LFSNHL: low frequency sensorineural hearing loss; VEMP: vestibular evoked myogenic potential; EcochG: electrocochleography; WFS1: Wolfram syndrome type 1 gene; DFNA: autosomal dominant deafness locus; DIAPH1: diaphanous; MYO7A: myosin VIIA (MYO7A); PCR: polymerase chain reaction; SP: summating potential; AP: action potential; LOD: log of the odds; dB: decibels; nHL: normalized hearing level.
###end p 46
###begin title 47
Competing interests
###end title 47
###begin p 48
The authors declare that they have no competing interests.
###end p 48
###begin title 49
Authors' contributions
###end title 49
###begin p 50
###xml 130 133 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
NFB elaborated the design of the study and conducted the DNA sequence analysis. JCK performed the microsatellite marker analysis. AMV investigated EcochG protocols and modified the consent forms appropriately. VAS collected blood samples and audiograms.
###end p 50
###begin title 51
Pre-publication history
###end title 51
###begin p 52
The pre-publication history for this paper can be accessed here:
###end p 52
###begin p 53

###end p 53
###begin title 54
Acknowledgements
###end title 54
###begin p 55
We want to thank the family that participated in this study. We appreciate project comments from Drs. Bruce Tempel, Richard Folsom, Lynne Werner, Charles Liberman, and Joe Adams. We thank Dr. Ning Zheng for conducting the protein bioinformatics analysis. We thank Andrew Shirk and Evan Thilo for comments on this paper. This work was funded by NIH grants DC04945 (V.A.S), DC006901 (V.A.S.) and P30 DC04661 (V.M. Bloedel Core).
###end p 55
###begin article-title 56
Hereditary Hearing Loss Homepage
###end article-title 56
###begin article-title 57
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 79 89 <span type="species:ncbi:7227">Drosophila</span>
Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous
###end article-title 57
###begin article-title 58
Modifier controls severity of a novel dominant low frequency Myosin VIIA (MYO7A) auditory mutation
###end article-title 58
###begin article-title 59
DFNA54, a third locus for low-frequency hearing loss.
###end article-title 59
###begin article-title 60
Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss
###end article-title 60
###begin article-title 61
A gene for autosomal dominant nonsyndromic hereditary hearing impairment maps to 4p16.3
###end article-title 61
###begin article-title 62
Non-syndromic progessive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1
###end article-title 62
###begin article-title 63
Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss
###end article-title 63
###begin article-title 64
###xml 54 62 <span type="species:ncbi:9606">patients</span>
A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfran syndrome)
###end article-title 64
###begin article-title 65
###xml 147 150 <span type="species:ncbi:10116">rat</span>
WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain
###end article-title 65
###begin article-title 66
Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein
###end article-title 66
###begin article-title 67
The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells
###end article-title 67
###begin article-title 68
p190-B, a new member of the Rho GAP family, and Rho are induced to cluster after integrin cross-linking
###end article-title 68
###begin article-title 69
Two families with nonsyndromic low-frequency hearing loss harbor novel mutations in Wolfram syndrome gene 1.
###end article-title 69
###begin article-title 70
Autosomal dominant non-syndromal low-frequency sensorineural hearing impairment linked to chromosome 4p16 (DFNA14): statistical analysis of hearing threshold in relation to age and evaluation of vestibulo-ocular functions
###end article-title 70
###begin article-title 71
A mutation in Wolfram syndrome type 1 gene in a Japanese family with autosomal dominant low-frequency sensorineural hearing loss
###end article-title 71
###begin article-title 72
Progression of low-frequency sensorineural hearing loss (DFNA6/14-WFS1)
###end article-title 72
###begin article-title 73
Dominantly inherited low-frequency hearing loss
###end article-title 73
###begin article-title 74
Otologic findings of DIDMOAD syndrome
###end article-title 74
###begin article-title 75
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Sex related hearing impairment in Wolfram syndrome patients identified by inactivating WFS1 mutations
###end article-title 75
###begin article-title 76
Phenotypic characterization of a DFNA6 family showing progressive low-frequency sensorineural hearing impairment
###end article-title 76
###begin article-title 77
Further characterization of the DFNA1 audiovestibular phenotype
###end article-title 77
###begin article-title 78
CEPH Genotype database
###end article-title 78
###begin article-title 79
Primer3 on the WWW for general users and for biologist programmers.
###end article-title 79
###begin article-title 80
Modifier controls severity of a novel dominant low-frequency Myosin VIIA (MYO7A) auditory mutation.
###end article-title 80
###begin article-title 81
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Molecular genetic analysis of distal mouse chromosome 6 defines gene order and positions of the deafwaddler and opisthotonos mutations
###end article-title 81
###begin article-title 82
Protein structure prediction servers at University College London
###end article-title 82
###begin article-title 83
Protein secondary structure prediction based on position-specific scoring matrices
###end article-title 83
###begin article-title 84
GenTHREADER: an efficient and reliable protein fold recognition method for genomic sequences
###end article-title 84
###begin article-title 85
Improving the accuracy of transmembrane protein topology prediction using evolutionary information
###end article-title 85
###begin article-title 86
A model recognition approach to the prediction of all-helical membrane protein structure and topology
###end article-title 86
###begin article-title 87
Improvement of the GenTHREADER method for genomic fold recognition
###end article-title 87
###begin article-title 88
FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded
###end article-title 88
###begin article-title 89
Sodium-potassium ATPase 1 subunit is a molecular partner of Wolframin, an endoplasmic reticulum protein involved in ER stress
###end article-title 89
###begin article-title 90
WFS1 Gene Mutation and Polymorphism Database
###end article-title 90
###begin article-title 91
###xml 26 34 <span type="species:ncbi:9606">patients</span>
Vestibular dysfunction of patients with mutations of Connexin 26
###end article-title 91
###begin article-title 92
###xml 34 42 <span type="species:ncbi:9606">patients</span>
Saccular dysfunction in Meniere's patients. A vestibular evoked myogenic potential study
###end article-title 92
###begin article-title 93
Abnormal vestibular evoked myogenic potentials in the presence of normal caloric responses
###end article-title 93
###begin article-title 94
High-frequency audiometry
###end article-title 94

